On-Demand Webinar on Combining fixed-bed bioreactors and resin-free affinity purification for stramlined, low-cost LVV manufacturing

Written By Mike Binder

LIVE WEBINAR from BioInsights, Originally Presented July 8th 2025

Join Nikki Votaw, PhD, Associate Director of R&D at Isolere Bio, and Thomas Robert, PhD, Senior Innovation & Product Manager at Universelles Technologies, as they reveal:

  • How fixed-bed bioreactors intensify and streamline LVV manufacturing, delivering up to 10x higher productivity.

  • A breakthrough resin-free affinity purification method using thermoresponsive proteins, achieving 4-log impurity reduction and ~30% functional vector recovery.

  • An optimized manufacturing workflow designed for the unique challenges of LVV production—cutting costs, time, and complexity.

Want to see how one integrated workflow can 10× your speed, cut costs in half, and fast-track your therapy to clinic—live in just 45 minutes?

Mike Binder
Next

Announcing Manufacturing-Grade IsoTag™ AAV Reagent